Skip to main content

Adverse Events

Horsies and Bunnies: Comparing Antithymocyte Globulin Drugs in Patients Undergoing Allogeneic Stem-Cell Transplant
Crystal Lu, PharmD, BCOP; Nancy Mikulandric, PharmD, BCOP; Meredith Grycki, PharmD, BCOP, BCPS; Vishnuprabha Vogel, PharmD, BCOP, BCPS; Shatha Farhan, MD; Edward Peres, MD; Nalini Janakiraman, MD; Klodiana Neme, PharmD, BCOP
Read More
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed-Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
Volkmar Böhme, MD; Ee Min Yeoh, BSc Pharm
Read More
Pharmacist-Run Chemotherapy-Induced Nausea and Vomiting Management Protocol Improves Patient Outcomes and Benefits Physician Workflow
David M. Hughes, PharmD, BCOP; Renee L. Vose, PharmD; Bhavesh Shah, RPh, BCOP; Radhika Jhaveri, PharmD, BCOP
Read More
Extended versus Intermittent Infusions of Piperacillin-Tazobactam in Patients with Febrile Neutropenia
Daniel J. Przybylski, PharmD; David J. Reeves, PharmD, BCOP
Read More
Prevention of Chemotherapy-Induced Nausea and Vomiting in Adult Patients Undergoing Hematopoietic Stem-Cell Transplant: Is Olanzapine an Option?
By Ariel Denson, PharmD; Alyshia Wiggins, PharmD; Allison Martin, PharmD, BCOP; Justin Arnall, PharmD, BCOP, CPP
Read More
Inadequate Transdermal Patch Absorption in a Patient with Scleroderma Associated with Graft-versus-Host Disease
Robert Mancini, PharmD, BCOP; Mallori Hooker, NP-C, AOCNP, BMTCN; William Kreisle, MD
Read More
Page 11 of 11
Results 101 - 106 of 106